The invention relates to pyrazolyl-based carboxamide compounds useful as ICRAC inhibitors, to pharmaceutical compositions containing these compounds and to methods of using these compounds for the treatment and/or prophylaxis of diseases and/or disorders, in particular inflammatory diseases and/or inflammatory disorders.
这项发明涉及以
吡唑基为基础的羧酰胺化合物,其作为ICRAC
抑制剂有用,涉及含有这些化合物的药物组合物以及使用这些化合物治疗和/或预防疾病和/或疾病的方法,特别是炎症性疾病和/或炎症性疾病。